NO20034350D0 - Optisk avbilding av kolorektal kreft - Google Patents

Optisk avbilding av kolorektal kreft

Info

Publication number
NO20034350D0
NO20034350D0 NO20034350A NO20034350A NO20034350D0 NO 20034350 D0 NO20034350 D0 NO 20034350D0 NO 20034350 A NO20034350 A NO 20034350A NO 20034350 A NO20034350 A NO 20034350A NO 20034350 D0 NO20034350 D0 NO 20034350D0
Authority
NO
Norway
Prior art keywords
optical imaging
colorectal cancer
colorectal
cancer
imaging
Prior art date
Application number
NO20034350A
Other languages
English (en)
Inventor
Jo Klaveness
Edvin Johannesen
Helge Tolleshaug
Original Assignee
Amersham Health As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amersham Health As filed Critical Amersham Health As
Priority to NO20034350A priority Critical patent/NO20034350D0/no
Publication of NO20034350D0 publication Critical patent/NO20034350D0/no
Priority to EP04775070A priority patent/EP1667734A2/en
Priority to US10/573,606 priority patent/US20060292078A1/en
Priority to PCT/NO2004/000287 priority patent/WO2005030266A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0032—Methine dyes, e.g. cyanine dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0052—Small organic molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20034350A 2003-09-29 2003-09-29 Optisk avbilding av kolorektal kreft NO20034350D0 (no)

Priority Applications (4)

Application Number Priority Date Filing Date Title
NO20034350A NO20034350D0 (no) 2003-09-29 2003-09-29 Optisk avbilding av kolorektal kreft
EP04775070A EP1667734A2 (en) 2003-09-29 2004-09-28 Optical imaging of colorectal cancer
US10/573,606 US20060292078A1 (en) 2003-09-29 2004-09-28 Optical imaging of colorectal cancer
PCT/NO2004/000287 WO2005030266A2 (en) 2003-09-29 2004-09-28 Optical imaging of colorectal cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20034350A NO20034350D0 (no) 2003-09-29 2003-09-29 Optisk avbilding av kolorektal kreft

Publications (1)

Publication Number Publication Date
NO20034350D0 true NO20034350D0 (no) 2003-09-29

Family

ID=29417560

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20034350A NO20034350D0 (no) 2003-09-29 2003-09-29 Optisk avbilding av kolorektal kreft

Country Status (4)

Country Link
US (1) US20060292078A1 (no)
EP (1) EP1667734A2 (no)
NO (1) NO20034350D0 (no)
WO (1) WO2005030266A2 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20034351D0 (no) * 2003-09-29 2003-09-29 Amersham Health As Optisk avbilding av endometrose
US7431914B2 (en) 2003-11-24 2008-10-07 Ge Healthcare As Contrast agent
NO20035683D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av prostatakreft
NO20035682D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av ösofagkreft og Barretts ösofag
NO20035681D0 (no) * 2003-12-18 2003-12-18 Amersham Health As Optisk avbildning av lungekreft
NO20035748D0 (no) * 2003-12-19 2003-12-19 Amersham Health As Optisk avbildning av sårbar arteriosklerose
US20080095704A1 (en) * 2004-07-02 2008-04-24 Alan Cuthbertson Imaging Agents with Improved Pharmacokinetic Profiles
CN101848734B (zh) * 2007-05-16 2013-08-28 通用电气医疗集团股份有限公司 用于成像的经标记的iigf结合肽
US20110262354A1 (en) 2007-07-13 2011-10-27 Emory University Cyanine-containing compounds for cancer imaging and treatment
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
WO2009152440A1 (en) * 2008-06-13 2009-12-17 Cedars-Sinai Medical Center Small molecule ligand-drug conjugates for targeted cancer therapy
GB201116862D0 (en) 2011-09-30 2011-11-09 Ge Healthcare As Infusion imaging method
GB2598676A (en) 2019-06-14 2022-03-09 Edinburgh Molecular Imaging Ltd Compounds and methods of use

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708265D0 (en) * 1997-04-24 1997-06-18 Nycomed Imaging As Contrast agents
AU2001288847A1 (en) * 2000-09-07 2002-03-22 Biosyntema Inc. Conformationally constrained labeled peptides for imaging and therapy
NO20004795D0 (no) * 2000-09-26 2000-09-26 Nycomed Imaging As Peptidbaserte forbindelser
US6656451B1 (en) * 2000-10-16 2003-12-02 Mallinckrodt, Inc. Indole compounds as novel dyes for organ function monitoring
NO20030115D0 (no) * 2003-01-09 2003-01-09 Amersham Health As Kontrastmiddel
HUE039154T2 (hu) * 2003-03-03 2018-12-28 Dyax Corp HGF receptort (cMet) specifikusan kötõ peptidek és alkalmazásaik
NO20033115D0 (no) * 2003-07-08 2003-07-08 Amersham Health As Peptid-baserte forbindelser

Also Published As

Publication number Publication date
WO2005030266A3 (en) 2005-06-16
US20060292078A1 (en) 2006-12-28
EP1667734A2 (en) 2006-06-14
WO2005030266A2 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
NO20053782D0 (no) Behandling av kreft med 2-deoksyglukose
LTC2269604I2 (lt) Inkstų solidinių navikų gydymas rapamicino dariniu
DK1948180T3 (da) Kombinationsbehandling af cancer omfattende EGFR/HER2 inhibitorer
DE112005003698A5 (de) Erfassung optischer Strahlung
IS8125A (is) Kínasólínafleiður til að meðhöndla krabbamein
DE602004000394D1 (de) Linsenabbildungssystem
NL1029763A1 (nl) Bereiding van gesubstitueerde chinazolinen.
DE602004017265D1 (de) Prognose von Kolorektalem Krebs
DE602005006458D1 (de) Abbildungslinse
DE60229847D1 (de) Computertomographie-bildgebung
DE602004006069D1 (de) Linsenabbildungssystem
DE602004026137D1 (de) Strahlungsdetektionskassette
DE602004022180D1 (de) Chinazolinderivate
DE602004004553D1 (de) Chinazolinderivate
NO20035681D0 (no) Optisk avbildning av lungekreft
NO20034350D0 (no) Optisk avbilding av kolorektal kreft
DE60228908D1 (de) Strahlungsdetektor
DE602004026172D1 (de) Optischer detektor der enzymaktivierung
SE0302837L (sv) Användning av IR-kamera
NO20035683D0 (no) Optisk avbildning av prostatakreft
DE60301365D1 (de) Optischer Verschiebungsdetektor
DE60110383D1 (de) Strahlungsdetektor
ATE366242T1 (de) 5-substituierte chinazolinonderivate
NO20055449D0 (no) Fremgangsmate for diagnostisering av behandling av kreft
FI20030657A0 (fi) Kuvausprofiili digitaalisessa kuvauksessa